InforMedix Holdings, Inc. (“InforMedix”), based in Rockville, Md, has developed the Med-eMonitor System – “Medication, Safe and Easy” in order to serve the estimated 50 million chronic care patients (U.S. only) who are on three or more medications.

The Company was founded by Bruce A. Kehr, M.D., who serves as Chairman & CEO. Dr. Kehr is Chairman of the Board of the Institute on Aging at the University of Pennsylvania. Dr. Kehr also has been named as one of the “100 Most Inspiring and Influential Leaders in the Life Sciences Industry” by PharmaVOICE.

The balance of the management team combines many decades of successful experience in diverse functional areas in the pharmaceutical, biotechnology and healthcare fields.

The Med-eMonitor System leverages InforMedix’s strong intellectual property. It consists of 15 issued patents and 14 patents pending. InforMedix’s patents have been cited as prior art by patent examiners in over 150 other issued patents.

InforMedix is a public company. Please follow this link for more investor information.